Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like ...

The Clear Oral Syringes Segment Held the Largest Share in 2024, Accounting for 62.9% of Total Revenues Oral Syringes Market ...

The Centers for Medicare and Medicaid Services (CMS) identified 15 drugs it has selected for price negotiations with drug ...

The causes of dyspneacan vary from physical exercise to pulmonary, car-diac ... Controlled trials show no clear benefit of inhaled opioids over oral or i.v. administration in the treatment ...

typically prescribed orally to patients with COPD during exacerbations, increase HF.33 The discrepancy could be due to the systemic effects of oral corticosteroids at very high doses and over a short ...

Analyst Joseph Schwartz of Leerink Partners reiterated a Buy rating on Insmed (INSM – Research Report), with a price target of $85.00.Stay ...

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces an oral ...

Treatment of infectious pulmonary exacerbations utilizes combinations of oral, inhaled and intravenous antibiotic agents. Chronic use of aerosolized antibiotics such as tobramycin or colistin ...

We have yet to find the cure for cancer, but there are ways to treat the disease and mitigate your risk of dying from it - ...

30, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces four oral ... of COPD allowing for broad use in COPD patients First inhaled ...